SignatureFD’s Soleno Therapeutics SLNO Stock Holding History

SignatureFD’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-131	Closed	-$4.39K	–	3622
2026 Q1	$4.39K	Buy	131 +120	+1,091%	+$4.71K	﹤0.01%	2826
2025 Q4	$509	Buy	+11	New	+$603	﹤0.01%	3230
2025 Q2	–	Sell	-2	Closed	-$143	–	3412
2025 Q1	$143	Buy	+2	New	+$97	﹤0.01%	3260

SignatureFD's SLNO Position: Q2 2026 in Review

SignatureFD sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 131 shares — an estimated $4.39K sold.

SignatureFD first reported a position in SLNO in Q1 2025 and held it in 3 quarters. The position peaked at $4.39K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

SignatureFD reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
SignatureFD sold 131 Soleno Therapeutics shares in Q2 2026, an estimated $4.39K.
SignatureFD first reported a position in Soleno Therapeutics in Q1 2025 and held it in 3 quarters.
SignatureFD's Soleno Therapeutics position peaked at $4.39K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.